| Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics E Miyauchi, T Furuta, S Ohtsuki, M Tachikawa, Y Uchida, H Sabit, ... PloS one 13 (3), e0193799, 2018 | 115 | 2018 |
| Quantitative atlas of cytochrome P450, UDP-glucuronosyltransferase, and transporter proteins in jejunum of morbidly obese subjects E Miyauchi, M Tachikawa, X Declèves, Y Uchida, JL Bouillot, C Poitou, ... Molecular pharmaceutics 13 (8), 2631-2640, 2016 | 88 | 2016 |
| Cluster of differentiation 46 Is the major receptor in human blood–brain barrier endothelial cells for uptake of exosomes derived from brain-metastatic melanoma cells (SK-Mel-28) H Kuroda, M Tachikawa, Y Yagi, M Umetsu, A Nurdin, E Miyauchi, ... Molecular pharmaceutics 16 (1), 292-304, 2018 | 74 | 2018 |
| High expression of UGT1A1/1A6 in monkey small intestine: comparison of protein expression levels of cytochromes P450, UDP-glucuronosyltransferases, and transporters in small … T Akazawa, Y Uchida, E Miyauchi, M Tachikawa, S Ohtsuki, T Terasaki Molecular pharmaceutics 15 (1), 127-140, 2018 | 38 | 2018 |
| Oral morphine pharmacokinetic in obesity: the role of P-glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 jejunal contents and obesity-associated biomarkers C Lloret-Linares, E Miyauchi, H Luo, L Labat, JL Bouillot, C Poitou, ... Molecular pharmaceutics 13 (3), 766-773, 2016 | 33 | 2016 |
| Global and targeted proteomics of prostate cancer cell secretome: combination of 2-dimensional image-converted analysis of liquid chromatography and mass spectrometry and in … A Nurdin, Y Hoshi, T Yoneyama, E Miyauchi, M Tachikawa, M Watanabe, ... Journal of Pharmaceutical Sciences 105 (11), 3440-3452, 2016 | 14 | 2016 |
| Identification of Blood–Brain Barrier-Permeable Proteins Derived from a Peripheral Organ: In Vivo and in Vitro Evidence of Blood-to-Brain Transport of Creatine Kinase K Sato, M Tachikawa, M Watanabe, E Miyauchi, Y Uchida, T Terasaki Molecular pharmaceutics 16 (1), 247-257, 2018 | 5 | 2018 |
